Elevance Health Inc
ELV
Get informed when a big investor buys or sells
+ FollowEarnings Call Q2 2026
July 15, 2026 - AI Summary
Exclusive for Stockcircle Pro members
Sign up
Current Fair Value
134.4% upsideUndervalued by 134.4% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $81.51 Billion |
|---|---|
| Enterprise Value | $102.32 Billion |
| Dividend Yield | $6.86 (1.83%) |
| Earnings per Share | $25.18 |
| Beta | 0.68 |
| Outstanding Shares | 217,900,000 |
Return
| Return on Equity | 11.06% |
|---|---|
| Return on Assets | 3.93% |
| Return on Invested Capital | 8.51% |
Valuation & Multiples
| P/E Ratio | 16.7 |
|---|---|
| PEG | -46.69 |
| Price to Sales | 0.42 |
| Price to Book Ratio | 1.86 |
| Enterprise Value to Revenue | 0.51 |
| Enterprise Value to EBIT | 14.63 |
| Enterprise Value to Net Income | 20 |
| Total Debt to Enterprise | 0.3 |
| Debt to Equity | 0.69 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Next Earnings Call
Institutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 1.1739▲ 58.70% |
|---|---|
| Total Calls | 23,000▼ 98.34% |
| Total Puts | 27,000▼ 96.68% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 6.38%▼ 81.97% |
|---|---|
| Total Invested | $5.25B▼ 90.79% |
| Investors Holding | 660▼ 850.00% |
ESG Score
No data
About Elevance Health Inc
83,400 employees
CEO: Gail Boudreaux Anthem is a leading health benefits company dedicated to improving lives and communities, and making healthcare simpler. Through its affiliated companies, Anthem serves more than 110 million people, including approximately 43 million wit...
Relevant Senate Committees
Provides critical analysis and scoring for tax legislation, directly influencing corporate tax structures and overall tax burden, which significantly impacts a large financial/insurance company like Elevance Health.
Directly controls taxation, trade, and crucial entitlement spending programs like Medicare and Medicaid, which are fundamental to Elevance Health's business model and profitability.
Directly allocates federal spending for health programs (e.g., Medicare, Medicaid, HHS), which are crucial funding sources and operational areas for Elevance Health.
Directly regulates significant aspects of the healthcare industry, including broad health policy, health insurance oversight, and labor laws that impact Elevance Health's operations.
Jurisdiction over antitrust laws and M&A directly impacts market consolidation and competitive practices within the health insurance industry, which is critical for a large player like Elevance Health.
Directly impacts federal healthcare spending ceilings for programs like Medicare and Medicaid, which are critical revenue sources and regulatory environments for Elevance Health.